These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 30071009)

  • 1. Transforming growth factor-β1 gene promoter -509C/T polymorphism in association with expression affects colorectal cancer development and depends on gender.
    Stanilova S; Stanilov N; Julianov A; Manolova I; Miteva L
    PLoS One; 2018; 13(8):e0201775. PubMed ID: 30071009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An updated meta-analysis on the association of TGF-β1 gene promoter -509C/T polymorphism with colorectal cancer risk.
    Wang Y; Yang H; Li L; Xia X
    Cytokine; 2013 Jan; 61(1):181-7. PubMed ID: 23084539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. -509C>T polymorphism in the TGF-β1 gene promoter is not associated with susceptibility to and progression of colorectal cancer in Chinese.
    Qi P; Ruan CP; Wang H; Zhou FG; Zhao YP; Gu X; Gao CF
    Colorectal Dis; 2010 Nov; 12(11):1153-8. PubMed ID: 19863608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Transforming Growth Factor-β1 Gene Polymorphism and Its Serum Levels in Hashimoto's Thyroiditis.
    Stanilova SA; Gerenova JB; Miteva LD; Manolova IM
    Curr Pharm Biotechnol; 2018; 19(7):581-589. PubMed ID: 30070177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Elevated Serum TGF-β1 and the Common Promoter
    Aleksandrova E; Mindov I; Petrov B; Dimitrova I; Petrov N; Ananiev J; Vlaykova T; Valkanov S
    Medicina (Kaunas); 2024 Jan; 60(1):. PubMed ID: 38256406
    [No Abstract]   [Full Text] [Related]  

  • 6. Promoter polymorphisms in TGFB1 and IL10 genes influence tumor dendritic cells infiltration, development and prognosis of colorectal cancer.
    Gulubova M; Aleksandrova E; Vlaykova T
    J Gene Med; 2018 Feb; 20(2-3):e3005. PubMed ID: 29388277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor beta1 -509C>T gene polymorphisms with gallbladder cancer.
    Vishnoi M; Pandey SN; Modi DR; Kumar A; Mittal B
    Hum Immunol; 2008 Jun; 69(6):360-7. PubMed ID: 18571008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of TGF-β1 -509C/T and 869T/C polymorphisms on glioma risk and patient prognosis.
    Vieira de Castro J; Gonçalves CS; Costa S; Linhares P; Vaz R; Nabiço R; Amorim J; Viana-Pereira M; Reis RM; Costa BM
    Tumour Biol; 2015 Aug; 36(8):6525-32. PubMed ID: 25813152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between the TGF-beta1 gene -509C/T polymorphism and tubulointerstitial damage resulting from primary nephrotic syndrome.
    Li Y; Liu FY; Peng YM; Li J; Sun L; Chen X; Duan SB; Ling GH; Guo N; Liu YH
    Ren Fail; 2010 May; 32(4):420-7. PubMed ID: 20446778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of transforming growth factor-beta1 gene polymorphisms with genetic susceptibility to nasopharyngeal carcinoma.
    Wei YS; Zhu YH; Du B; Yang ZH; Liang WB; Lv ML; Kuang XH; Tai SH; Zhao Y; Zhang L
    Clin Chim Acta; 2007 May; 380(1-2):165-9. PubMed ID: 17368597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The -509C/T polymorphism of transforming growth factor-beta1 is associated with increased risk for development of chronic idiopathic neutropenia.
    Eliopoulos DG; Mavroudi I; Pontikoglou C; Ximeri M; Stavroulaki E; Pyrovolaki K; Velegraki M; Spanoudakis M; Goulielmos G; Papadaki HA
    Eur J Haematol; 2009 Dec; 83(6):535-40. PubMed ID: 19614955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. -509C>T polymorphism in the TGF-beta1 gene promoter, impact on the hepatocellular carcinoma risk in Chinese patients with chronic hepatitis B virus infection.
    Qi P; Chen YM; Wang H; Fang M; Ji Q; Zhao YP; Sun XJ; Liu Y; Gao CF
    Cancer Immunol Immunother; 2009 Sep; 58(9):1433-40. PubMed ID: 19169878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphism -509C/T in
    Zhu XJ; Lu MP; Chen RX; Bu DY; Zhu LP; Wang ML; Yin M; Zhang ZD; Cheng L
    Am J Rhinol Allergy; 2020 Sep; 34(5):597-603. PubMed ID: 32216462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis on polymorphism at -509 C/T site of TGF-β1 gene in patients with keloids].
    Song M; Liu Y
    Zhonghua Shao Shang Za Zhi; 2014 Dec; 30(6):482-6. PubMed ID: 25608783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphism in the transforming growth factor beta1 gene (-509 C/T and -800 G/A) and colorectal cancer.
    Amirghofran Z; Jalali SA; Ghaderi A; Hosseini SV
    Cancer Genet Cytogenet; 2009 Apr; 190(1):21-5. PubMed ID: 19264229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A link between promoter polymorphisms of the transforming growth factor β1 (TGFB1) and TGF-β1 receptor II (TGFBR2) genes and relapsing-remitting multiple sclerosis.
    Grigorova A; Trenova A; Stanilova S
    Folia Neuropathol; 2020; 58(4):307-316. PubMed ID: 33480235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic association and gene expression profiles of TGFB1 and the contribution of TGFB1 to otosclerosis susceptibility.
    Priyadarshi S; Ray CS; Panda KC; Desai A; Nayak SR; Biswal NC; Ramchander PV
    J Bone Miner Res; 2013 Dec; 28(12):2490-7. PubMed ID: 23703862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of TGF-β1 expression and -509C>T polymorphism in the TGF-β1 gene on the progression and survival of gastric cancer.
    Ananiev J; Manolova I; Aleksandrova E; Gulubova M
    Pol J Pathol; 2017; 68(3):234-240. PubMed ID: 29363915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are SMAD7 rs4939827 and CHI3L1 rs4950928 polymorphisms associated with colorectal cancer in Egyptian patients?
    Abd El-Fattah AA; Sadik NA; Shaker OG; Kamal AM
    Tumour Biol; 2016 Jul; 37(7):9387-97. PubMed ID: 26779637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of TGF-beta1 (-509C>T) promoter polymorphism in susceptibility to cervical cancer.
    Singh H; Jain M; Mittal B
    Oncol Res; 2009; 18(1):41-5. PubMed ID: 19911703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.